Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome

This study has been completed.

First Received on July 3, 2001. Last Updated on January 20, 2009 History of Changes

Sponsor:	Department of Veterans Affairs
Information provided by:	Department of Veterans Affairs
ClinicalTrials.gov Identifier:	NCT00018837

Purpose

The goal of this research program is to implement a series of psychoeducational training classes designed to teach individuals with schizophrenia the importance of medication treatment, how to identify and manage medication side effects, and how to make appointments and emergency plans. The skills taught to the research subjects will lead to demonstrable increases (compared to the control group) in adherence to both the prescribed medication regimen and scheduled outpatient appointments and thereby cause a decrease (again compared to the control group) in rehospitalization rates and bed-days during subsequent twelve months following the intervention. A secondary objective of this work is that if the CREP program is successful and/or illness education is effective, the data will be able to disseminated throughout the VISN 22 via the recently awarded Mental Illness Research Education and Clinical Center (MIRECC) program.

Condition	Intervention
Schizophrenia Schizophrenic Disorder	Behavioral: Community Re-Entry Program: What is Schizophrenia

Study Type:	Interventional
Study Design:	Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment
Official Title:	Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome

Resource links provided by NLM:

MedlinePlus related topics: Schizophrenia

U.S. FDA Resources

Further study details as provided by Department of Veterans Affairs:

Study Start Date:	April 1998
Estimated Study Completion Date:	March 2001

Eligibility

Ages Eligible for Study:	18 Years to 65 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Age 18-65 years of age.
DSM IV diagnosis of schizophrenia or schizoaffective disorder.
Competent to give informed consent.
Previously participated in "Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome" Principal Investigator. Donna Wirshing, M.D.

Exclusion Criteria:

Physical or cognitive impairment of such severity as to adversely affect the validity of clinical ratings or impair capacity to give informed consent.
History of substantial substance dependence 6 months prior to the study.
Patients at high risk of suicide or other directed violence.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018837

Locations

United States, California
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States, 90073

Sponsors and Collaborators

Department of Veterans Affairs

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00018837 History of Changes
Other Study ID Numbers:	MHBS-010-98S
Study First Received:	July 3, 2001
Last Updated:	January 20, 2009
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on February 09, 2012